Multimodal Imaging Techniques in Assessing the Surgical Risk for Eloquent Arteriovenous Malformations
MITASREAVM
The Efficacy of Multimodal Magnetic Resonance Imaging Techniques in Assessing the Surgical Risk for Eloquent Arteriovenous Malformations
1 other identifier
interventional
400
1 country
1
Brief Summary
Microsurgical resection for eloquent arteriovenous malformations (AVMs) remains challenging. Currently, there are only two grading systems concerning pretreatment assessment of brain AVMs: the Spetzler-Martin grading system proposed by Spetzler and Martin in 1986 and the supplementary grading system proposed by Lawton in 2010. Controversies exist regarding the treatment timing and treatment modalities for eloquent AVMs. Till now, there is no clinical trial concerning the efficacy of multimodal magnetic resonance imaging techniques in assessing the surgical risk for eloquent AVMs. The investigators assume that multimodal imaging-based grading system is superior to the classic Spetzler-Martin grading system and the supplementary grading system in predicting the surgical risk for eloquent AVMs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 25, 2016
CompletedFirst Posted
Study publicly available on registry
August 16, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedAugust 16, 2016
August 1, 2016
3 years
July 25, 2016
August 13, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
neurologic status measured by modified Rankin scale score
the changes of modified Rankin scale (mRS) score six months after AVM surgery compared with the presurgical mRS score
six months after AVM surgery
Secondary Outcomes (7)
number of patient deaths
within 6 months after surgery
AVM obliteration confirmed by postoperative DSA or CTA
within one week after surgery
AVM rebleeding confirmed by CT scan
within 6 months after surgery
Seizure control measured by Engel classification
within 6 months after surgery
muscle strength measured by muscle strength grading scale
6 months after surgery
- +2 more secondary outcomes
Study Arms (1)
fMRI guided AVM resection
EXPERIMENTALfMRI guided microsurgical resection of brain AVMs
Interventions
fMRI guided microsurgical resection of brain AVMs
Eligibility Criteria
You may qualify if:
- Patients aged between 12 and 60 years
- Data from preoperative structural MRI, blood oxygen level dependent (BOLD)-fMRI, time-of-flight magnetic resonance angiography (TOF-MRA), and DTI of the motor tract,language tract or optic radiation were available
- Patients with a definite diagnosis of AVM confirmed by preoperative digital subtraction angiography
- Patients opting for surgical management at the five centers in this study
- Patients without any interventional therapy (microsurgery, radiosurgery, endovascular embolization, or multimodality treatment) before admission to the five centers
You may not qualify if:
- Patients with acute intracranial hematoma and resultant brain hernia prompting emergency surgery
- Patients with a hemorrhagic incident in the past month
- Nonavailability of BOLD-fMRI and DTI data
- Patients with other severe diseases that prevented them from having surgery
- Patients unwilling to participate in the trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beijing Tiantan Hospitallead
- Chinese PLA General Hospitalcollaborator
- Beijing Hospitalcollaborator
- Xuanwu Hospital, Beijingcollaborator
- Beijing Friendship Hospitalcollaborator
Study Sites (1)
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, 100050, China
Related Publications (4)
Wen Z, Zheng K, Guo S, Liu Y, Wang K, Liu Q, Wu J, Wang S. The difference of functional MR imaging in evaluating outcome of patients with diffuse and compact brain arteriovenous malformation. Neurosurg Rev. 2024 Jul 24;47(1):347. doi: 10.1007/s10143-024-02593-9.
PMID: 39043982DERIVEDJiao Y, Lin F, Wu J, Li H, Fu W, Huo R, Cao Y, Wang S, Zhao J. Plasticity in language cortex and white matter tracts after resection of dominant inferior parietal lobule arteriovenous malformations: a combined fMRI and DTI study. J Neurosurg. 2020 Mar 20;134(3):953-960. doi: 10.3171/2019.12.JNS191987. Print 2021 Mar 1.
PMID: 32197246DERIVEDLi M, Jiang P, Guo R, Liu Q, Yang S, Wu J, Cao Y, Wang S. A Tractography-Based Grading Scale of Brain Arteriovenous Malformations Close to the Corticospinal Tract to Predict Motor Outcome After Surgery. Front Neurol. 2019 Jul 17;10:761. doi: 10.3389/fneur.2019.00761. eCollection 2019.
PMID: 31379715DERIVEDTong X, Wu J, Cao Y, Zhao Y, Wang S. New predictive model for microsurgical outcome of intracranial arteriovenous malformations: study protocol. BMJ Open. 2017 Jan 27;7(1):e014063. doi: 10.1136/bmjopen-2016-014063.
PMID: 28132013DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Shuo Wang, M.D.
Beijing Tiantan Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 25, 2016
First Posted
August 16, 2016
Study Start
June 1, 2016
Primary Completion
June 1, 2019
Study Completion
December 1, 2019
Last Updated
August 16, 2016
Record last verified: 2016-08
Data Sharing
- IPD Sharing
- Will not share